Pharming Group N.V. (AMS: PHARM)
Netherlands
· Delayed Price · Currency is EUR 0.881
+0.025 (2.86%)
Dec 20, 2024, 5:35 PM CET
Pharming Group Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Jan '20 Jan 1, 2020 | 2019 - 2015 |
| Net Income | -17.82 | -10.55 | 13.67 | 16 | 37.75 | 40.56 | Upgrade
|
| Depreciation & Amortization | 10.13 | 10.13 | 8.09 | 9.17 | 8.31 | 6.62 | Upgrade
|
| Other Amortization | 0.88 | 0.88 | 0.72 | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.2 | -21.28 | - | - | - | - | Upgrade
|
| Asset Writedown & Restructuring Costs | 4.92 | 4.92 | 4.38 | 10.44 | - | -0.82 | Upgrade
|
| Loss (Gain) From Sale of Investments | -4.23 | 0.93 | -11.06 | -0.11 | -0.07 | - | Upgrade
|
| Loss (Gain) on Equity Investments | 0.61 | 0.29 | 1.08 | -0.69 | -0.36 | -0.26 | Upgrade
|
| Stock-Based Compensation | 11.92 | 9.25 | 6.39 | 9.06 | 6.54 | 4.29 | Upgrade
|
| Other Operating Activities | -1.39 | 5.09 | -0.44 | -1.05 | 35.38 | 23.32 | Upgrade
|
| Change in Accounts Receivable | -7.68 | -18.54 | 2.36 | 5.92 | -7.04 | -7.81 | Upgrade
|
| Change in Inventory | -8.57 | -14.43 | -15.02 | -6.15 | -4.93 | 4.24 | Upgrade
|
| Change in Accounts Payable | 12.46 | 16.23 | 11.99 | -5.19 | 7.02 | 6.86 | Upgrade
|
| Change in Unearned Revenue | - | - | - | - | - | -1.73 | Upgrade
|
| Change in Other Net Operating Assets | -0.58 | -0.22 | 0.27 | 0.47 | 1.04 | -1.12 | Upgrade
|
| Operating Cash Flow | 0.45 | -17.3 | 22.46 | 37.84 | 83.63 | 74.15 | Upgrade
|
| Operating Cash Flow Growth | - | - | -40.65% | -54.75% | 12.78% | 83.65% | Upgrade
|
| Capital Expenditures | -0.96 | -1.44 | -1.38 | -10.74 | -4.66 | -2.65 | Upgrade
|
| Sale (Purchase) of Intangibles | 0.15 | 21.25 | -0.6 | -5.98 | -10.64 | -22.81 | Upgrade
|
| Investment in Securities | 38.32 | -149.2 | 7.3 | -4.59 | -0.33 | -2.81 | Upgrade
|
| Other Investing Activities | - | - | - | - | - | 0 | Upgrade
|
| Investing Cash Flow | 37.5 | -129.39 | 5.32 | -21.31 | -15.63 | -28.26 | Upgrade
|
| Long-Term Debt Issued | - | - | - | - | 142.83 | - | Upgrade
|
| Total Debt Issued | 104.54 | - | - | - | 142.83 | - | Upgrade
|
| Long-Term Debt Repaid | - | -5.13 | -3.31 | -3.22 | -59.42 | -37.39 | Upgrade
|
| Total Debt Repaid | -139.52 | -5.13 | -3.31 | -3.22 | -59.42 | -37.39 | Upgrade
|
| Net Debt Issued (Repaid) | -34.98 | -5.13 | -3.31 | -3.22 | 83.41 | -37.39 | Upgrade
|
| Issuance of Common Stock | 3.74 | 8.13 | 2.28 | 4.72 | 2.79 | 3.11 | Upgrade
|
| Other Financing Activities | -1.99 | -4.05 | -3.95 | -29.45 | -25.51 | -29.19 | Upgrade
|
| Financing Cash Flow | -33.23 | -1.04 | -4.98 | -27.95 | 60.69 | -63.47 | Upgrade
|
| Foreign Exchange Rate Adjustments | 1.29 | 2.13 | -7.38 | -1.83 | 2.13 | 0.06 | Upgrade
|
| Net Cash Flow | 6.01 | -145.6 | 15.42 | -13.24 | 130.81 | -17.52 | Upgrade
|
| Free Cash Flow | -0.51 | -18.74 | 21.08 | 27.1 | 78.97 | 71.5 | Upgrade
|
| Free Cash Flow Growth | - | - | -22.22% | -65.68% | 10.44% | 88.76% | Upgrade
|
| Free Cash Flow Margin | -0.18% | -7.64% | 10.25% | 13.63% | 37.22% | 37.75% | Upgrade
|
| Free Cash Flow Per Share | -0.00 | -0.03 | 0.03 | 0.04 | 0.12 | 0.11 | Upgrade
|
| Cash Interest Paid | 1.99 | 4.05 | 3.95 | 4.45 | 2.14 | 9.43 | Upgrade
|
| Cash Income Tax Paid | 14.52 | 0.66 | 1.24 | - | 2.66 | 5.71 | Upgrade
|
| Levered Free Cash Flow | 4.49 | 8.06 | 15.71 | -17.14 | 44.3 | 22.43 | Upgrade
|
| Unlevered Free Cash Flow | 10.01 | 11.78 | 19.06 | -13.33 | 48.01 | 30.78 | Upgrade
|
| Change in Net Working Capital | 6.16 | 14.7 | 0.65 | 29.84 | 1.07 | -2.48 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.